Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1250 of 1294 entries
View as:

Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00537303 Org: User:
Start: 10/31/07 End: 03/31/09 Due: 03/31/10

A Research Study in People With Type 2 Diabetes to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine

Phase: N/A Priority: Normal
NCT ID: NCT03922750 Org: User:
Start: 05/09/19 End: 01/27/20 Due: 01/27/21

Special Use - Results Surveillance on Long-term Use With Wegovy®

Phase: N/A Priority: Normal
NCT ID: NCT06283667 Org: User:
Start: 06/11/24 End: 01/31/28 Due: 01/31/29

Use of Activated Recombinant Human Factor VII to Reduce Bleeding Caused by Warfarin Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01561937 Org: User:
Start: 01/31/07 End: 07/31/08 Due: 07/31/09

Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01541215 Org: User:
Start: 11/13/12 End: 05/20/20 Due: 05/20/21

A Research Study to Compare Two Different Forms of Once-weekly Semaglutide in Two Different Injection Pens

Phase: N/A Priority: Normal
NCT ID: NCT04238962 Org: User:
Start: 02/03/20 End: 10/20/20 Due: 10/20/21

A Research Study Looking Into Blood Levels of Three Different Formulations of the Study Medicine Ziltivekimab

Phase: N/A Priority: Normal
NCT ID: NCT05721989 Org: User:
Start: 02/03/23 End: 01/08/24 Due: 01/08/25

Investigation of Single Ascending Doses of NNC9204-1706 in Male Subjects Being Overweight or With Obesity

Phase: N/A Priority: Normal
NCT ID: NCT03095807 Org: User:
Start: 03/20/17 End: 08/31/17 Due: 08/31/18

Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00154401 Org: User:
Start: 01/31/05 End: 10/31/05 Due: 10/31/06

Safety and Tolerability of Insulin Degludec/Liraglutide (A3) in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01319240 Org: User:
Start: 03/31/11 End: 05/31/11 Due: 05/31/12

A Trial to Investigate Different Needle Features Assessed by Comparing Insulin Aspart Pharmacokinetic Profiles

Phase: N/A Priority: Normal
NCT ID: NCT02594033 Org: User:
Start: 10/27/15 End: 01/28/16 Due: 01/28/17

A Research Study Looking at Long-term Blood Sugar Control in People With Type 2 Diabetes Being Treated With Xultophy® in a Real-world Setting in Italy

Phase: N/A Priority: Normal
NCT ID: NCT04666987 Org: User:
Start: 10/21/20 End: 02/10/23 Due: 02/10/24

Investigation of the Pharmacokinetics of NNC172-2021, at Two Different Dose Levels, in Healthy Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01555749 Org: User:
Start: 03/12/12 End: 05/08/12 Due: 05/08/13

A Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Nephrologists

Phase: N/A Priority: Normal
NCT ID: NCT06322641 Org: User:
Start: 03/26/24 End: 05/10/24 Due: 05/10/25

Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01707160 Org: User:
Start: 11/30/95 End: 12/31/95 Due: 12/31/96

Observational Study of Patients Using Levemir® or Insulatard® as Start Insulin for Treatment of Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00715351 Org: User:
Start: 05/31/07 End: 07/31/08 Due: 07/31/09

A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation IV

Phase: N/A Priority: Normal
NCT ID: NCT06642584 Org: User:
Start: 10/15/24 End: 05/25/25 Due: 05/25/26

A Research Study of How Safe a New Medicine Called NNC0519 0130 is and to Test Its Effect in People Living With Excess Body Weight With or Without Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT06567041 Org: User:
Start: 08/07/24 End: 12/03/25 Due: 12/03/26

A Research Study in Chinese Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day.

Phase: N/A Priority: Normal
NCT ID: NCT04970654 Org: User:
Start: 07/22/21 End: 12/18/23 Due: 12/18/24

A Trial Investigating the Pharmacokinetic Properties of NN1218 in Subjects With Diabetes Mellitus, Type 1

Phase: N/A Priority: Normal
NCT ID: NCT01296438 Org: User:
Start: 02/28/11 End: 03/31/11 Due: 03/31/12

Special Survey for Long Term Application

Phase: N/A Priority: Normal
NCT ID: NCT01516229 Org: User:
Start: 05/01/97 End: 03/31/07 Due: 03/31/08

Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)

Phase: N/A Priority: Normal
NCT ID: NCT03972345 Org: User:
Start: 06/21/19 End: 06/30/31 Due: 06/30/32

Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ryzodeg®

Phase: N/A Priority: Normal
NCT ID: NCT02821052 Org: User:
Start: 07/01/16 End: 11/24/18 Due: 11/24/19

SEMA-CardioDiab HUNGARY: A Research Study to Understand the Effects of Oral Semaglutide on Blood Sugar Levels, Weight, and Cardiovascular Risk in People With Type 2 Diabetes Patients in Hungary

Phase: N/A Priority: Normal
NCT ID: NCT06269120 Org: User:
Start: 09/30/24 End: 09/30/25 Due: 09/30/26

High Dose of Activated Recombinant Human Factor VII for Treatment of Mild/Moderate Joint Bleeds in Haemophilia Patients With Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT00571584 Org: User:
Start: 11/30/02 End: 03/31/04 Due: 03/31/05